Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
Teva Pharm finalizing asset sales to clear Allergan deal: source
Teva Pharmaceutical Industries Ltd is finalizing as much as $2 billion in asset sale agreements to win U.
Valeant forms internal committee to oversee drug pricing
Valeant Pharmaceuticals International Inc, which has acknowledged mistakes in its drug pricing practices amid U.
US biotech firm gets permission to conduct groundbreaking trial to bring back to life central nervous system of clinically dead patients
Another groundbreaking medical experiment is expected to create buzz and controversy similar to when Italian surgeon Sergio Canavero announced plans to perform the world’s first head transplant on a...
Japanese scientists have used skin cells to restore a patient's vision for the first time
Japanese scientists have reported the first successful skin-to-eye stem cell transplant in humans, where stem cells derived from a patient's skin were transplanted into her eye to partially restor...
Pfizer Needs Clearer Goals
Pfizer’s record with mergers hardly inspires confidence.
EC approves eribulin for the treatment of advanced liposarcoma
The European Commission (EC) has approved a variation to the terms of the Marketing Authorisation (MA) of Eisai’s eribulin for the treatment of adult patients with unresectable lipos...
Nuplazid approved for Parkinson's hallucinations
MONDAY, May 2, 2016 -- Nuplazid (pimavanserin) has been approved by the U.
Abilify gets potential for binge eating, sex urges added to label
Abilify (aripiprazole)One of the potential side effects listed for the antipsychotic Abilify and its generics is an uncontrollable urge to gamble.
Pfizer approaches Medivation about possible takeover: Sources
Pfizer has approached U.
U.S. prosecutors consider more charges against ex-CEO Shkreli
Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, appears before a House Oversight and Government Reform hearing on Capitol Hill in Washington.
A 'sewer' or not a 'sewer'? Buffett, Ackman butt heads over Valeant
Monday saw a verbal battle of the billionaires between Bill Ackman and Warren Buffett.
Biogen Spinning Off Hemophilia Business As Competition Heats Up
Big biotech Biogen (BIIB) said Tuesday that it will spin off its hemophilia business into an independent company in a move much anticipated by Wall Street.
36
37
38
39
40
41
42
43
44
